netFormulary NHS
North East and North Cumbria
ICS Formulary
 Search
 Recent Updates - Updated items

All Formulary Amendments

  Records 1 to 12 of 12


Details
LDL Link Added : MHRA Drug Safety Update (Jan 2018): Recombinant human erythropoietins: very rare risk of severe cutaneous adverse reactions (SCARs) : https://www.gov.uk/drug-safety-update/recombinant-human-erythropoietins-very-rare-risk-of-severe-cutaneous-a
12/07/2023 09:04:00
(ebeavers )
LUP Section link 19346 Updated: 09.01.03 : Shared Care Guidelines for the Monitoring of Erythropoietins in the Treatment of Patients with Chronic Kidney Disease (CKD) : http://www.northoftyneapc.nhs.uk/wp-content/uploads/sites/6/2023/01/Erythropoietin-fo...
14/02/2023 14:02:08
(DavidS )
UPD Epoetin beta (NeoRecormon®) updated
15/04/2021 14:51:54
(DavidS )
UPD Epoetin beta (NeoRecormon®) updated
15/04/2021 14:49:14
(DavidS )
LDL Link Added : Shared Care Guidelines for the Monitoring of Erythropoietin (Darbepoetin [Aranesp]) in the Treatment of Patients with Chronic Kidney Disease (CKD) : http://www.northoftyneapc.nhs.uk/wp-content/uploads/sites/6/2018/01/Erythropoietin-for-CKD-SC
20/02/2018 09:50:05
(DavidS )
UPD Epoetin beta (NeoRecormon®) updated
20/02/2018 09:49:32
(DavidS )
UPD Epoetin beta (NeoRecormon®) updated
20/02/2018 09:49:22
(DavidS )
UPD Epoetin beta (NeoRecormon®) b
01/02/2017 14:08:51
(WhitehallJ )
UPD Epoetin beta (NeoRecormon®) b
01/02/2017 14:08:00
(WhitehallJ )
UPD Epoetin beta (NeoRecormon®) b
23/01/2017 15:02:31
(DavidS )
UPD Epoetin beta (NeoRecormon®) b
23/01/2017 15:02:12
(DavidS )
UPD Epoetin beta (NeoRecormon®) Build
29/11/2016 10:38:15
(ClarkH )

 

 

netFormulary